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Abstract 
The HFE molecule controls iron uptake from gut, and defects in the molecule 
have been associated with iron overload, particularly in hereditary 
hemochromatosis. The HFE gene including both coding and boundary intronic 
regions were sequenced in 304 Brazilian individuals, encompassing healthy 
individuals and patients exhibiting hereditary or acquired iron overload. Six 
sites of variation were detected: i) H63D C>G in exon 2, ii) IVS2 (+4) T>C in 
intron 2, iii) a C>G transversion in intron 3, iv) C282Y G>A in exon 4, v) IVS4 
(-44) T>C in intron 4, and vi) a new Guanine deletion (G>del) in intron 5, 
which were used for haplotype inference. Nine HFE alleles were detected and 
six of these were officially named on the basis of the HLA Nomenclature, 
defined by the WHO Nomenclature Committee for Factors of the HLA System, 
and published via the IPD-IMGT/HLA website. Four alleles, HFE*001, 002, 
003 and 004 exhibited variation within their exon sequences. 
Introduction 
The HFE gene (abbreviation of High Fe) is located at the 6p21.3 telomeric 
chromosomal region of the extended Major Histocompatibility Complex 
(MHC), and it is considered to be a non-classical HLA class I-like gene (1, 2). 
HFE is composed of seven exons, translating in to 348 amino acids of the α-
chain of the HFE molecule, which comprises three extracellular domains, a 
transmembrane region and a cytoplasmic tail. Exon 1 encodes the signal 
peptide, exons 2, 3 and 4 encode the α1, α2 and α3 domains respectively, exon 5 
encodes the transmembrane domain and exon 6 the cytoplasmic tail (3). The 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
HFE molecule contains four highly conserved Cysteine residues, which form 
two intramolecular disulfide bridges (C225 and C282) in the α3 domain (4). 
The α2 and α3 domains are essential for the tertiary structure of the protein and 
for the interaction of the α3 domain with β2-microglobulin, enabling HFE 
expression on the cell surface (5). The protein encoded by the HFE gene is 
strongly related to the regulation of intestinal iron absorption (6, 7). 
 
The HFE gene exhibits many previously described single nucleotide 
polymorphisms (SNPs), as illustrated in Table 1. However, only three of these 
have been frequently studied: C282Y, H63D and S65C (5, 8, 9). As the 
relationship between these SNPs has not been systematically evaluated, we 
undertook a study of the coding and boundary intronic regions of the HFE gene 
in a selected Brazilian population. As there was no standardized nomenclature 
for the HFE gene, we worked with the WHO Nomenclature Committee for 
Factors of the HLA System, to provide official allele names for a number of 
HFE alleles (10). 
The HFE coding region (exons 2, 3, 4, 5) and boundary introns were sequenced 
(Figure 1) in a Brazilian population sample consisting of 100 healthy 
individuals and 204 patients exhibiting hereditary (hereditary 
hemochromatosis, n=14) or acquired diseases (hepatitis C, n=130 and 
hepatocellular carcinoma, n=60) associated with liver iron overload. 
DNA samples were extracted from peripheral blood cells using a salting-out 
procedure. Each exon was individually amplified by polymerase-chain reaction 
(PCR) using the sets of primers shown in Table 2. Primers were designed using 
the GENNERUNNER v.3.05 software (Hastings Software, Inc., Hastings, NY) 
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and the tools of the UCSC Genome Bioinformatics group 
(http://genome.ucsc.edu). An illustration of the amplified HFE segments is 
shown in Figure 1. Exons were amplified in a final volume of 50 µL, 
containing 1X PCR buffer [70 mM Tris-HCl pH 8.8, 20 mM (NH4)2SO4], 3 
mM MgCl2, 1mM dithiothreitol, 0.2 mM of each dNTP, 10 pmol of each 
primer, 1.1 units of Taq DNA-polymerase (Platinum-Invitrogen, Carlsbad, 
CA), and 200 ng of genomic DNA. The initial denaturation cycle was carried 
out at 94°C for 5 minutes, followed by 30 cycles of 45 seconds at 94°C, 45 
seconds at annealing temperature and 1 minute at 72°C, and by a final 
extension step at 72°C for 7 minutes. Amplification products were directly 
sequenced (ABI 3500 Genetic Analyzer, Applied Biosystems, Foster City, 
CA), using the same primers designed for amplification, according to 
manufacturer’s instructions. 
Observed SNPs were used to assemble the genetic profile of these samples and 
to reconstruct HFE haplotypes by two computational procedures: i) the ELB 
algorithm implemented by the ARLEQUIN v3.1 (11) software (alpha value: 
0.01; epsilon value: 0.01; gamma value: 0; sampling interval: 500; burn-in 
steps: 100,000; recombination steps: 0), and ii) the PHASE method [number of 
iterations: 1000 (iterations in the final run increased 10 times); thinning 
interval: 1; burn-in value: 100; 5 value for each locus: 1; number of 
independent runs: 10], implemented by the PHASE v.2. software (12). To 
obtain consensual and reliable haplotypes for each sample, haplotype estimates 
were performed using several simulations, in which population samples were 
input as a single group. 
Working with the WHO Nomenclature Committee for factors of the HLA 
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System, we established a standardized nomenclature for HFE alleles (Figure 2), 
using as reference the HLA Nomenclature described by Marsh et al (10), as 
described below: 
1. Each HFE allele name has a unique number that corresponds up to three 
fields. The first field contains three digits and the following two fields 
contain two digits, each field is separated by a colon.  
2. The first field is used to list the allele group, the number is assigned 
sequentially in the order in which the allele was determined, each number 
corresponding to a specific protein sequence. Alleles whose names differ 
in the first field must differ by one or more non-synonymous nucleotide 
substitutions altering the amino acid sequence of the protein. 
3. The second field is used to indicate synonymous nucleotide differences 
between alleles within the coding region. 
4. The third field is used to designate alleles that differ only by intronic 
nucleotide variation. 
5. All allele names are a minimum of one field in length, additional fields 
are added only when necessary due to the discovery of related allele 
sequences.  
To validate sequences, extended amplifications (introns 2-5) were performed 
for genomic (double stranded DNA) and cloned (single stranded DNA) 
samples. To obtain representatives single strand DNA samples, the following 
procedures were performed: i) purification of the extended (introns 2-5) PCR 
products (Jetx PCR-DNA and Gel Band Purification Kit, GE Healthcare, 
Buckinghamshire, UK), ii) ligation of each PCR product to pGEM®-T easy 
vector system (Promega, Madison, WI), iii) insertion of the vector into bacteria 
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by thermal shock, iv) growth of transformed bacteria in culture medium (LB 
Agar, Fisher-Scientific, Hampton, New Hampshire), containing 200 mg/mL 
ampicillin and 40 mg/mL Xgal (Ludwig Biotec, Alvorada, Brazil), and v) 
purification of each cloned DNA samples using the Illustra plasmid prep mini 
spin Kit (GE Healthcare). The products obtained were directly sequenced (ABI 
3500 Genetic Analyzer), using the same primers designed for amplification, 
according to manufacturer’s instructions. 
Five recognized SNPs and a new mutation were observed in the HFE gene: i) 
H63D C>G at exon 2 (rs1799945), ii) IVS2 (+4) T>C at intron 2 (rs2071303), 
iii) the intron 3 C>G (rs807209), iv) C282Y G>A at exon 4 (rs1800562), v) 
IVS4 (-44) T>C at intron 4 (rs1800708), and vi) a new Guanine deletion 
(G>del) in intron 5. The sequence that included this new mutation is shown in 
the electropherogram in Figure 3. This fragment was cloned and amplified by 
EXON5 pair of primers, covering the whole exon 5 and a partial cover of 
introns 4 and 5, since the last intron holds the recently annotated mutation. The 
identification of SNPs was retrieved from the NCBI 
(http://www.ncbi.nlm.nih.gov) and Ensembl (http://www.ensembl.org) 
databases. 
 
The haplotype inference analysis yielded nine alleles, of which four HFE*001, *002, 
*003, and *004 allele groups, encompassing only SNPs at exonic sequences (Table 3), 
were validated as official HFE alleles and published via the IPD-IMGT/HLA website 
(http://www.ebi.ac.uk/ipd/imgt/hla/), release number 3.27.0 (20170120) (13, 14). A 
single sample showed a discordant result by the ELB method in only one simulation by 
ARLEQUIN software v.3.1 (10), while all other simulations provided identical results, 
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regardless of the method or population structure evaluated. The discordant haplotype 
showed low probability of occurrence (0.092), when recalculated by PHASE v.2 
software (12). 
This study enabled us to define a number of HFE allele sequences and receive 
official names for these alleles. By so doing we were able to link a number of 
polymorphic sites that has previously been observed within the HFE gene, and 
link these within the allele sequences. In addition, the study of Brazilian 
healthy individuals, which constitutes a highly genetically diverse population 
and the study of an array of patients exhibiting hereditary or acquired liver iron 
overload (associated with the HFE gene) may permit a wide recognition of the 
HFE coding and boundary intron region variability. Finally, the standardization 
of the HFE gene nomenclature will help on the definition of new HFE alleles 
on future studies.  
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TABLES 
 
Table 1. Previous names of the most important variation sites observed at the HFE 
gene, and their reference SNP numbers (rsIDs#). The most studied HFE SNPs are in 
bold type. 
Current name used in 
literature rsIDs # Gene position
* 
V53M  rs28934889  +8641G>A (exon 2) 
V59M  rs111033557 +8659G>A (exon 2) 
H63D rs1799945 +8671C>G (exon 2) 
S65C  rs1800730) +8677A>T (exon 2) 
IVS2 (+4) T>C rs2071303 +8828T>C (intron 2) 
Q127H rs28934595  +9074A>C (exon 3) 
E168Q   rs146519482  +9195G>C (exon 3) 
C282Y rs1800562 +10633G>A (exon 4) 
Q283P rs111033563 +10636A>C (exon 4) 
E168Q   rs146519482 +9195G>C (exon 4) 
W169T  rs797045145er  +9199G>A (exon 4) 
IVS4 (-44) T>C rs1800708 +10795T>C (intron 4) 
* According to the HFE RefSeq gene sequence NG_008720.2, which is the 
HFE*001:01:01 allele 
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Table 2. Description of HFE gene target regions, including the sequences of the 
primers used to amplify the complete coding and boundary introns region and those 
used for partial segment amplification. The annealing temperatures and the amplicon 
lengths are also shown. 
Amplified 
Region Primer sequences 
Annealing 
temperature 
Amplicon 
length 
Intron 1 to 
Intron 5 
HFE- complete coding region Forward –  
5´- GTGGCAGAGAAAAGCACACAAG – 3´ 
HFE- complete coding region Reverse–  
5´- GAGACTTTCATTCTGGGGAG – 3´ 
60ºC  2,757 kbp 
Intron 1 
(partial) 
Exon 2 
Intron 2 
(partial) 
HFEexon2F: 
5´-GCTGATGGTATGAGTTGATGC-3´ 
HFEexon2R: 
5´-CTCAGACTTCCAGCTGTTTC-3´ 
60ºC 444 bp 
Intron 2 
(partial) 
Exon 3 
Intron 3 
(partial) 
HFEexon3F: 
5´-GCTTCCTGAGATCATTTGGTCC-3´ 
HFEexon3R: 
5´-CAGAATTTGGAGAGGCACACAG-3´ 
59ºC 485 bp 
Intron 3 
(partial) 
Exon 4 
Intron 4 
(partial) 
HFEexon4F: 
5´- CTGATCTGACTGCTCTCCAAGTG-3´ 
HFEexon4R: 
5´-CATAATTACCTCCTCAGGCAC-3´ 
53ºC 545 bp 
Intron 4 
(partial) 
Exon 5 
Intron 5 
(partial) 
HFEexon5F: 
5´-GTGCCTGAGGAGGTAATTATGG-3´ 
HFEexon5R: 
5´-CTTCCCATGGATGCCAGATC-3´ 
58ºC 308 bp 
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Table 3. Allele identification and haplotype composition of nucleotide variations observed along the coding 
and boundary introns region of the HFE gene observed in Brazilian individuals. Mutated bases are indicated 
in boldface and variation sites at exonic regions are highlightened in grey.  
Allele 
identification 
Haplotype composition 
Previous 
nomenclature
 
+3511a +3668b +5197c +5473d +5635e +5811f 
 
HFE*001:01:01† C T C G T G  
HFE*001:01:unofficial2†† C C C G T G  
HFE*001:01:unofficial3†† C T G G T G  
HFE*001:01:unofficial 4†† C T C G C G  
HFE*001:01:unofficial5†† C C C G C G  
HFE*001:01:unofficial6†† C C G G T del  
HFE*002 † G C C G T G H63D 
HFE*003† C T C A T G C282Y 
HFE*004† G C C A T G H63D/C282Y 
Identification of SNPs and most frequent allele according to NCBI (http://www.ncbi.nlm.nih.gov) and 
Ensembl (http://www.ensembl.org). Nucleotide locations were assigned considering the first transcribed 
base as +1: a - rs1799945 (H63D); b - rs2071303 (IVS2 (+4) T>C); c - rs807209; d - rs1800562 (C282Y); e 
- rs1800708 (IVS4 (-44) T>C); f - deletion of a Guanine at intron 5. 
†Alleles submited by our research group, and published via the IPD-IMGT/HLA Database  
(http://www.ebi.ac.uk/ipd/imgt/hla/) (1, 14). Validation covering the whole gene  region (exonic and 
intronic) by next generation sequence is in course.  
††These alleles are designated as unofficial, since they do not present official names assigned by IPD-IMGT/HLA. 
Intronic regions harboring these mutations must be cloned and sequenced in order to obtain an official nomenclature. 
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